Methotrexate Plus Biologic More Effective in RA : Federal report on rheumatoid arthritis therapies praised as a good summation of years of literature.

Dr. Abramson, who is also vice dean for education, faculty and academic affairs at New York University, New York, called the lack of head-to-head trials of biologic DMARDs “a weakness of this field. These are the studies that do need to get done, particularly with respect to x-ray progression.”

To access the full report online, visit www.effectivehealthcare.ahrq.gov/reports/final.cfm